{"filings":[{"id":295385,"accession_number":"0001477932-23-003695","cik":1435181,"company_name":"Pharmagreen Biotech Inc.","ticker":"PHBI","form_type":"8-K","filed_at":"2023-05-18T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Pharmagreen Biotech replaces auditor; Sadler, Gibb resigns, Turner Stone appointed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sadler, Gibb & Associates resigned as auditor on April 27, 2023; no disagreements on accounting or audit scope.","Board appointed Turner, Stone & Company as new independent registered public accounting firm effective May 4, 2023.","No prior consultations with Turner Stone on accounting principles, transactions, or audit opinions.","Reports for fiscal year ended Sept 30, 2022 from Sadler, Gibb contained no adverse opinion or qualification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":622210.9090909092,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334245,"accession_number":"0001477932-22-009028","cik":1435181,"company_name":"Pharmagreen Biotech Inc.","ticker":"PHBI","form_type":"8-K","filed_at":"2022-12-02T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Pharmagreen issues $50K convertible note at 42.5% discount; hires Tyrell Crosby for 10M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Convertible promissory note: $50,000 principal, 10% interest, due May 1, 2023; conversion price is 57.5% of average 3 lowest trading prices (42.5% discount).","Note issued to accredited investor JanBella Group LLC under Regulation D; company may prepay at 125% within 120 days, no prepayment after.","Product endorsement agreement with NFL player Tyrell Crosby: receives 10M common shares for 1.5-year term as brand ambassador for NutraMax Genomic Supplement.","Crosby also entitled to $1,000 per day plus travel expenses for appearances at company events or shows.","Company had approximately 444.8M shares outstanding prior to these issuances; potential dilution from note conversion and share issuance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":622210.9090909092,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":351669,"accession_number":"0001477932-22-005820","cik":1435181,"company_name":"Pharmagreen Biotech Inc.","ticker":"PHBI","form_type":"8-K","filed_at":"2022-08-11T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Pharmagreen Biotech replaces auditor Saturna Group with Sadler Gibb","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Saturna Group resigned as independent auditor on Aug 1, 2022; no disagreements with management.","Board appointed Sadler Gibb & Associates as new auditor for fiscal year ending Sep 30, 2022.","Prior audit reports (FY2020, FY2021) included going-concern explanatory paragraph but no adverse opinions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":622210.9090909092,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":425243,"accession_number":"0001477932-21-005939","cik":1435181,"company_name":"Pharmagreen Biotech Inc.","ticker":"PHBI","form_type":"8-K","filed_at":"2021-08-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pharmagreen Biotech enters broadcast agreement, issues 6M shares for marketing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement with New to the Street Group for one-year broadcast on Newsmax, CNBC, CNN, FOX NEWS, and others.","Issued 6,000,000 restricted shares as payment for first three months; remaining months at $40,000/month in cash or shares.","Option to add 100 additional commercials per month at $40,000/month.","Separate services agreement with FlinnWest Solutions for website, pitch deck, video, and CRM build for $26,500 (CA).","Payment for FlinnWest includes $13,125 upon signing and $13,125 after qualification of Form 1-A offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":622210.9090909092,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}